0001694665-21-000019.txt : 20210129
0001694665-21-000019.hdr.sgml : 20210129
20210129172829
ACCESSION NUMBER: 0001694665-21-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210127
FILED AS OF DATE: 20210129
DATE AS OF CHANGE: 20210129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zung Jonathan B.
CENTRAL INDEX KEY: 0001837972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 21572974
MAIL ADDRESS:
STREET 1: C/O EVELO BIOSCIENCES, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 200 WEST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 870 8281
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 200 WEST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_161195929825887.xml
FORM 4
X0306
4
2021-01-27
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001837972
Zung Jonathan B.
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Development Officer
Stock Option (Right to Buy)
16.65
2021-01-27
4
A
0
300000
0
A
2031-01-27
Common Stock
300000.0
300000
D
This option will vest as to 25% of the total grant on January 4, 2022 and the remainder vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.
/s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung
2021-01-29